Terlipressin plus norepinephrine for kidney injury in liver failure with septic shock
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether adding a continuous infusion of terlipressin (a medicine that helps raise blood pressure and protect kidneys) to standard norepinephrine treatment improves kidney recovery in people with acute-on-chronic liver failure, acute kidney injury, and septic shock.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have acute-on-chronic liver failure (a sudden worsening of chronic liver disease).
- You have acute kidney injury (a sudden drop in kidney function).
- You have septic shock (a severe infection causing very low blood pressure) and are already on a small dose of norepinephrine (a blood pressure medicine).
- You have not used terlipressin in the last 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares giving terlipressin as a continuous infusion versus as a bolus for people with ACLF who have bleeding from varices in the esophagus. The goal is to see which method works better and is safer.
This trial tests whether a treatment called therapeutic plasma exchange (a process that filters your blood) can help improve the function of other organs in people with severe liver failure. It aims to see if this treatment leads to better outcomes and to find markers that predict who will benefit.
This trial tests whether giving albumin (a blood protein) in a personalized dose works better than a standard fixed dose for people with cirrhosis and sepsis-related acute kidney injury. The goal is to find a safer and more effective way to protect kidney function.
This trial tests whether different blood pressure medicines protect kidney function better in people with septic shock (a severe infection that causes low blood pressure). It compares norepinephrine (the standard treatment) with other options to see which is best for the kidneys.
This trial tests whether giving fluids and norepinephrine together early can prevent kidney injury in people with septic shock. If you are in the ICU or ER with septic shock, this treatment might help protect your kidneys.
This trial tests whether guiding fluid and medication adjustments with a non-invasive monitoring tool helps prevent kidney damage in people with septic shock. The tool measures a pressure related to blood flow without needing additional invasive procedures.
Hear when a new Acute-On-Chronic Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.